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HONORS ABSTRACT
The question of what makes humans human is one of philosophical discussion, but it runs the
risk of bypassing the knowledge that humans are animals existing in a world filled with other
organisms. These organisms interact with humans constantly. Considering that humans do not
exist independently of other organisms, we are impacted by the evolutionary direction that they
take. Therefore, if we have a desire to live alongside other creatures, humans have the
responsibility to understand how other organisms intermingle with us. Mycoplasma genitalium
is a sexually transmitted bacterium that can cause persistent infections lasting from months to
years by using adhesin proteins to bind to the epithelial cells of the host’s genital tract. Previous
research on antigenic variation in the adhesin proteins MgpB and MgpC suggests that M.
genitalium may use this variation to evade the immune system. Antibodies depend on specific
binding to ensure that they connect to a particular pathogen with high binding affinity. It is
suggested that the variation in the adhesin proteins creates a difference in the protein tertiary
structure to the point the extent that antibodies no longer bind as well, allowing for the
perseverance of the bacteria and persistence of the infection. We used surface plasmon
resonance (SPR) to study the binding kinetics of antibodies from immunized rabbits and
experimentally infected primates to recombinant MgpB protein fragments. We find that
association kinetics of the MgpB:B variants were reduced when compared to the MgpB:B wild
type.
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ABSTRACT
Infections caused by Mycoplasma genitalium, a human genital tract pathogen, often persist
for months to years. Antigenic variation of the immunodominant adhesin proteins, MgpB and
MgpC, is thought to enhance persistence by avoiding specific antibody-dependent immune
clearance. We used surface plasmon resonance (SPR) to study the binding of antibodies from
immunized rabbits and experimentally infected primates to recombinant MgpB protein
fragments. Primate antibodies collected from 2 weeks before to 2, 4, and 8 weeks after infection
associated specifically with two different domains of the MgpB adherence protein (variable
region B and a conserved C-terminal region) bound via amine coupling to the surfaces of CM5
sensor chips. Association and dissociation kinetics were measured and used to calculate
dissociation constants (KD values). Association kinetics varied by 80-fold over the 14 antibodyantigen combinations tested, while dissociation kinetics varied by only 4-fold, suggesting that
association kinetics describe the interactions better than dissociation.
In general, antibodies from later time points in the immune response bound antigens more
tightly and more quickly, as expected from the process of affinity maturation. Antibodies bound
best to the conserved C-terminal region, increasing in affinity from 300 nM to 5 nM for antibodies
4 or more weeks after infection. Binding to variable region B also increased from 300 nM to 5
nM, but highest affinity was measured 2 weeks after infection, after which affinity decreased.
Binding was lowest to a variant B region that predominated 8 weeks after infection. Antibodies
before infection bound with weak (1 μM) affinity, increasing to around 300 nM after infection.
None of the antibody samples bound the variant B region with better than high-nanomolar
affinity. Overall, we measured that antibody affinity increased by 7- to 20-fold after infection, but
that this could be counteracted by sequence variation that reduced peak affinity by 2- to 3-fold.
INTRODUCTION
Mycoplasma genitalium, sporting the smallest genome of any known free-living organism
(Glass, et al., 2005) can cause acute and chronic urethritis in men and likely cervicitis and pelvic
inflammatory disease in women (Gnanadurai & Fifer, 2020). Along with urethritis, M. genitalium
has been associated with more severe HIV and cancer development (Zarei, Rezania, & Mousavi,
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2013). By adhering to the epithelial cells within the urinary tract, the bacterium enters the host
and causes an inflammatory response. Despite the immune response, it has been shown that
untreated infections can last for months to years. The chronic nature and incessant symptom
presentation suggest that M. genitalium evades immune recognition.
The tip organelle of M. genitalium contains the two adhesin proteins, MgpB and MgpC
(McGowin & Totten, 2017). The bacterium’s genome contains regions homologous to the genes
that code for adhesin proteins. Previous studies have shown that M. genitalium utilizes these
homologous regions to generate recombinant proteins in within the tip organelle. With the many
variable regions present within the adhesin proteins, crossed with the many homologous copies
contained in the genome, there are many variants possible. The way in which the organism
utilizes this recombination to evade the immune system is of great interest and is the focus of
our research. Most antibiotics currently available work by targeting bacterial cell walls; without
the cell wall, many bacteria lack the integrity to survive in the host. M. genitalium does not have
a cell wall, so the antibiotics that are available to target it are minimal (Bradshaw, Jensen, &
Waites, 2017). The available antibiotics that do work against M. genitalium are becoming futile
as the percentage of antibiotic-resistant bacteria continues to rise. Successful treatment options
depend on the understanding of how M. genitalium is able to avoid the host’s immune response.
The recombinant regions of MgpB are B, EF, and G (Figure 1). We evaluated the kinetic
signatures of antibodies from rabbits and primates with recombinant MgpB:B protein fragments.
We used surface plasmon resonance to evaluate the association and dissociation kinetics of
antibody-antigen binding at the intervals of 2 weeks prior to inoculation, 2 weeks after infection,
4 weeks after infection, and 8 weeks after infection. This was compared to the association and
dissociation kinetics of antibody-antigen binding using the same intervals for a week 8 variant.

Figure 1: A diagram representing the variants present in the MgpB adhesin protein. Variable
regions are in yellow and labeled B, EF, and G. rMgpB-B is the recombinant protein fragment we
used (Iverson-Cabral, Wood, & Totten, 2015).
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MATERIALS AND METHODS
We used a BIAcore X Surface Plasmon Resonance (SPR) instrument (Figure 2) to detect protein
binding events. Antibodies were purified from sera of rabbits and primates infected with
recombinant protein and M. genitalium, respectively. Three BIAcore chips were made by either
amine-coupling MgpB:4a (a conserved region) protein fragment to the chip surface, aminecoupling MgpB:B:G37 (wild-type) protein fragment to the chip surface or amine-coupling MgpB:B
Wk8 (variant) protein fragment to the chip surface. Varying concentrations of primate antibody
from Wk-2, Wk2, Wk4, and Wk8 were run over the chips.
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Figure 2: (Top) The Seattle Pacific University BIAcore X machine allows for collecting binding
occurrences from SPR. (Bottom) SPR is able to express protein binding by measuring the change
in the angle of reflection in a beam of light. As binding occurs, the angle of reflection is slightly
altered. SPR allows for the change to be measured in real time. Image is taken from Sabban, Sari
(2011 PhD thesis), The University of Sheffield.
Surface Plasmon Resonance (SPR) Data Collection
General Information
All data collection was performed at 25°C using the same BIAcore X machine and BIAcore X
control software. The machine was blanked using HBSEP buffer solution before samples were run
and frequently during collection. Flow channel 1 was set as the blank flow channel, and all results
are based on flow cell 2 – flow cell 1 values. Flow cell 1 did not have any antigen bound whereas
flow cell 2 was set up to have antigen bound via amine-coupling. The machine was desorbed
every Tuesday and sanitized the first Tuesday of the month during data collection. Desorption
used BIAdesorb solution 1 (0.5% (w/v) sodium dodecyl sulphate) and BIAdesorb solution 2 (50
mM glycine at pH 9.5). Sanitization was performed using 7% of a 10-15% bleach solution.

Determining pH for Amine-Coupling
In order to combine the protein to the chip, the antigen needed to be charged for optimal
binding. We used various pH solutions to test which pH would be best for the coupling reaction.
The settings for the BIAcore machine were set at multichannel, rate of 10μL/min, and flow cell 1
used as the reference cell. We inserted a blank CM5 chip into the docking mechanism and
allowed HBSEP to run flush through the inlet tube and onto the chip for a few minutes. We used
sodium acetate at pH of 4.05, 4.51, 5.08, and 5.49 to dilute protein to 1:5. These samples were
injected, and the 1:5 solution at pH 4.51 showed the best results for coupling by showing the
highest response difference present in flow cell 2.

Amine-Coupling
Amine-coupling is necessary to bind the protein of interest to the surface of the chip. The first
step is to activate and block the blank surface (flow cell 1). The settings for this were singlechannel, flow cell1 as reference, and the rate was 10 μL/min. The flow cell surface was cleaned
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with a 10 μL (35 μL) solution of 50 mM NaOH. We then injected 25 μL (60 μL) of a 1:1 NHS:EDC
mixture, and we finished the cleaning with an injection of 35 μL (60 μL) ethanolamine solution.
We then needed to activate, couple, and block the flow cell 2 protein surface. This was done by
setting the machine to single-channel, reference cell 2, and a baseline flow to 10μL/min; we
started a continuous flow of HBSEP. The flow cell was set to 2 so that our antigen only bound in
that channel. We injected 25 μL (60 μL) of a 1:1 solution of NHS:EDC (N-hydroxysuccinimide at a
concentration of 0.1 M in water and 0.4 M 1-ethyl-3-[3-dimethylaminopropyl]-carbodiimide
hydrochloride in water). We then injected 80 μL (110 μL) of the protein:acetate solution (a 1:5
solution of 15 μL antigen (MgpB:C4a-1, MgpB:B G37 or MgpB:B Wk8 variant) and 85 μL pH 4.51
acetate). A 25 μL (50 μL) ethanolamine solution was injected to block any remaining areas to bind
to reduce false binding responses.

Regeneration of Surface
Previous research on this project has utilized NaOH as a method of regenerating the chip
surface. We found that the binding events of the primate antibodies were weaker than the
previous year’s rabbit antibodies, and the wash procedure that occurred after the sample had
been run through was sufficient in removing any extra analyte.
Antibody Concentrations
Primate A01220 Antibody Concentrations
Wk-2

0.913 mg/mL

Wk2

0.939 mg/mL

Wk4

0.961 mg/mL

Wk8

0.746 mg/mL

Table 1: Original concentrations of primate A01220 antibodies from various weeks.

To ensure that the concentrations, once diluted, were comparable between the G37 chip and
the Wk8 variant chip, dilutions were made to get as close to a similar concentration as possible.
The concentrations used on the Wk8 variant chip were doubled due to reduced binding activity.
Antibodies were mixed with HBSEP buffer to achieve desired concentration.
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Primate A01220
Antibody used on
MgpB:B G37 Chip
Wk-2

Concentration Range

1:608, 1:304, 1:152,

Primate A01220
Antibody used on
MgpB:B Wk8 Variant
Chip
Wk-2

1:76, 1:38, 1:19
Wk2

1:640, 1:320, 1:160,

1:640, 1:320, 1:160,

Wk2

1:496.64, 1:248.32,

1:320, 1:160, 1:80,
1:40, 1:20, 1:10

Wk4

1:80, 1:40, 1:20
Wk8

1:304, 1:152, 1:76,
1:38, 1:19, 1:9.5

1:80, 1:40, 1:20
Wk4

Concentration Range

1:320, 1:160, 1:80,
1:40, 1:20, 1:10

Wk8

1:248.32, 1:124.16,

1:124.16, 1:62.08,

1:62.08, 1:31.04,

1:31.04, 1:15.52

1:15.52, 1:7.75

Table 2: Concentration gradients used during data collection for both the G37 and Wk8 variant
chips.

Ligand Placed on Chip Surface
Initial Concentration Received
MgpB:C4a-1
1.00 mg/mL
MgpB:B G37
0.32 mg/mL
MgpB:B Wk8
0.59 mg/mL
Table3: Antigen initial concentrations that were used to make the chips.
Data Collection
All trials followed the same procedure for collecting data. BIAcore was set to multi-channel,
FC2-1 run with flow cell 1 used as reference, and a flow rate of 40 μL/min. The wash was set for
a 180 second delay. The first injection was a 60 μL (90+5+5+5 μL) HBSEP solution. Once the
baseline had steadied, concentrations (shown in Table 2) were made and injected using the
volume 60 μL (90+5+5+5 μL). After each cycle, an additional 250 seconds were left between the
samples to allow the baseline to return to the initial position. Four trials were taken for each
sample.
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Data Processing
BIAevaluation was used to process the data of the binding curves. Each trial was analyzed
individually for the kinetic data. We used a 1:1 Langmuir binding model to fit both the association
and dissociation kinetics. From this, we were able to determine the kon and koff values. With these
values, the overall KD value was determined (Figure 3).

Figure 3: Figure taken from Wang, Yan, and Goult’s paper on force-dependent binding constants
(Wang, Yan, & Goult, 2019). A shows the act of ligands binding and then dissociating. B shows the
graphical representation of the association and dissociation occurring on the chip. The equations
given can be used to calculate kinetic constants using BIAevaluation software.
RESULTS AND DISCUSSION
The two regions studied during this project were MgpB:B and MgpB:C4a-1 with the former
tested with the G37 wild type and a Wk8 variant. Figure 4 demonstrates the regions in which
these fragments make up the MgpB adhesin protein.
Figure 4: Using PYMOL
and the PDB ID 6RUT,
the 3D structure of
MgpB can be visualized
with regions B (blue)
and
C4a
(yellow)
contributing to much
of the surface.
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Our findings show that dissociation rates do not change much between the G37 wild-type and
the Wk8 variant as the dissociation kinetics only varied about 4-fold (Table4).
ka

SE(ka)

kd

SE(kd)

Chip (Antibody)

KD

16043.67

5659.333

0.00395

0.000462 4a(wk-2)

2.46E-07

22280

8891.708

0.008226

0.001093 4a(wk2)

3.69E-07

122339.8

21855.45

0.004822

0.000725 4a(wk4)

3.94E-08

64566.67

13231

0.003532

0.000449 4a(wk8)

5.47E-08

11410

5232.278

0.003823

0.000677 B(Pwk-2)

3.35E-07

90993.89

35357.22

0.004794

0.001069 B(Pwk2)

5.27E-08

32868.33

17344.44

0.007477

0.001361 B(Pwk4)

2.76E-07

12444.17

5535.333

0.004191

0.000973 B(Pwk8)

3.37E-07

1492.783

996.4833

0.002618

0.000244 Bwk8(Pwk-2)

1.75E-06

18423.61

6254.167

0.003044

0.000579 Bwk8(Pwk2)

1.86E-07

30191.46

12774.17

0.011513

0.002859 Bwk8(Pwk4)

3.81E-07

12227.08

3847.917

0.004565

0.000513 Bwk8(Pwk8)

3.73E-07

72850

1511.25

0.002678

0.000156 B(G37)(rab)

3.68E-08

44350

2643.5

0.003063

0.000344 Bwk8(rab)

6.91E-08

Table 4: Kinetic binding for ka and kd with total KD. Binding affinity ranges from tight (green) to
weak (red). Rab stands for rabbit primates that were studied prior to the primate antibodies.
The dissociation kinetics vary by 4-fold whereas the association kinetics 80-fold; the
association kinetics describe the interaction between bacterium and antibody better than the
dissociation. The primate antibody flown over the MgpB:C4a-1 chip demonstrated increased
binding from Wk-2 to Wk4; association binding began to decrease by Wk8 (Figure 5). Primate
antibody interacted weakly with the MgpB:B chip during Wk-2 and increased to its tightest
binding during Wk2. It steadily decreased through weeks 4 and 8 (Figure 6). The lowest binding
was seen between the primate antibody and the MgpB:B Wk8 variant chip with extremely low
binding during Wk-2 and steadier binding until Wk4, when binding became weaker for Wk8
(Figure 7).
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Figure 5: kon-koff plot for the group of tests done between primate antibodies (from 2 weeks before
inoculation to 8 weeks post inoculation) run over an MgpB:C4a-1 chip. Between weeks -2 and 4,
association binding gets stronger. Between weeks 4 and 8, the association between antibody and
antigen weakens.
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Figure 6: kon-koff plot for the group of tests done between primate antibodies (from 2 weeks before
inoculation to 8 weeks post inoculation) run over an MgpB:B. Between weeks -2 and 2, association
binding gets stronger. Wk4 antibodies bind less strongly than Wk2, and Wk8 antibodies show a
similar affinity for the antigen as antibodies that have never been exposed to MgpB:B.

Figure 7: kon-koff plot for the group of tests done between primate antibodies (from 2 weeks before
inoculation to 8 weeks post inoculation) run over an MgpB:B Wk8 variant chip. Wk-2 showed
incredibly low affinity for the antigen, even lower primate(wk-2)+B in the previous figure. The
highest association occurred with the Wk4 antibodies.
Our findings also show that the variation leads to reduced antibody-antigen association
kinetics. The association kinetics of the 14 combinations tested varies by 80-fold. The general
finding is that antibodies bound better later during the infection. Studies on region B show that
the highest affinity, however, was during 2 weeks after infection. After those two weeks (as
shown by Wk4 and Wk8), binding affinity decreased. The results of antibody being bound to Wk8
variant antigen showed much lower binding affinities and a peak affinity during Wk4 (which was
similar to the binding of Wk4 for the G37 antigen). It is important to note that the binding
between the BWk8 variants and the Wk-2 antibodies is almost not detected. When compared to
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the better binding of BG37 to the Wk-2 antibodies (antibodies that have never seen this antigen),
it suggests that the region is varied so as to not bind antibodies in general, not just specific
antibodies.

CONCLUSION
Understanding how Mycoplasma genitalium evades the immune response of the host is
imperative to generating successful treatment plans. Understanding how M. genitalium evades
the immune response in vitro is a necessary step in that process. Recognizing how variation within
the M. genitalium genome can affect association and dissociation kinetics can provide insight
into how the surface of the protein (in this case the tip organelle) affects the ability of the immune
response. Our data show that these variations are affecting the initial binding between antigen
and antibody suggesting that an alteration in the surface of the protein is preventing antibodies
from binding. Future work on other protein fragments in the MgpB genome as well as the protein
fragments of the other adhesin protein, MgpC, will help in determining how variation allows this
bacterium to continue to evade the immune system. We hope to continue work using human
sera on the recombinant proteins that have studied here as well as the others in MgpB and MgpC.
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APPENDIX
Our panel’s discussion on the responsibilities of humans will work its way up from the micro
to the macro duties that present themselves in our lives. The driving point of this discussion will
be to recognize that we do not exist independently. We do not exist independently of other
citizens. We do not exist independently of our peers. We do not exist independently of other
organisms. Beginning with the micro responsibilities of humans, it is imperative to recognize that
we do not exist in our bodies alone. The human body contains its own ecosystem of microbes.
Some of these will be working symbiotically with us while others are with us purely for their own
gain, using us as a mere means for their own benefit.
One such microorganism is Mycoplasma genitalium. This bacterium exists with a size of about
300nm and a genome consisting of 482 genes. For reference, this the smallest genome on record.
M. genitalium is sexually transmitted, and I would be remiss if during a discussion on human
responsibility and a cause of STDs that I didn’t point out the duty to be responsible during physical
relations. MG can affect both men and women. In men there will be cases of urethritis. In women,
there will be cases of cervicitis, pelvic inflammatory disease, preterm birth, infertility, and an
increased acquisition and transmission of HIV. Prior endeavors to combat bacterial infections
gave rise to antibiotics like penicillin. Unfortunately, penicillin is only useful against bacteria that
contain a cell wall, something that M. genitalium lacks. There are antibiotics that could work
against MG, specifically azithromycin and moxifloxacin. Azithromycin works by inhibiting
bacterial protein synthesis. Without proteins, the cell cannot function. Moxifloxacin is a
fluoroquinolone that interferes with DNA gyrase during DNA synthesis within the bacterium so
that it cannot replicate. However, MG infections are becoming increasingly resistant to the
present options. Now we have the task of finding new treatment options for this bacterium or
else be infected indefinitely. Some people who have the resistant strains have been infected for
years. They depend on scientists to understand how this bacterium evades its attackers so that
it can be targeted and the infection it causes can be stopped.
M. genitalium, though, does not want to be stopped. Along with the antibiotics that it has had
to overcome, MG infections have to fight off the body’s own defense mechanism: the immune
system. After a pathogen has found a way past the first barrier, whether through the skin, eyes,
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nose, or urogenital openings, macrophages work to consume the invading bacteria. Once they
recognize and consume a threat, they can send out signals to neutrophils which will come to the
location and secrete toxins to kill the bacteria. Dendritic cells will also get involved. Dendritic cells
are known as APCs or antigen-presenting cells. They will take in the pathogen, break it apart, and
present sections of it on its cell surface. Bacterial pathogens will be taken to the lymph nodes
where there will be a T-cell that can recognize the antigen presented on the dendritic cell. While
some of those T cells will stay in the lymph node for later immunity and some will go to the site
of infection, others will continue on to the center of the lymph node and find a matching B cell.
These B cells will make antibodies specific to the antigen. The antibodies will bind specifically to
their targeted region either blocking the pathogen from entering the cell or recruiting cells and
molecules to kill the bacterium.
Just as the human body is working to combat this infection, the bacterium is working to avoid

being killed. Within the entire genome of
MG, there are two important proteins, the
adhesin proteins. MgpB and MgpC make
up the proteins found on the tip organelle
of MG. This tip organelle is what allows MG
to bind to epithelial cells found in the reproductive tract and get inside the body. The pictures
above the adhesin proteins are the prote in crystal structure of MgpB taken from 4 different
angles. I colored the structure based on the regions that my research focused on which I will get
into a bit later. The yellow region is called 4a and the blue region is called B. The picture on the
bottom right is the entire M. genitalium genome with the MgPa operon and MgPar regions
labeled. The operon region is the region responsible for expressing the actual protein. These par
regions contain the genetic information for the protein, but they are not being expressed. The
picture in the top right is a closer look at the operon region. The genes of the unlabeled proteins
are shown in white and are conserved regions. You’ll also notice that there are certain regions
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labeled as B, EF, G, and KLM. These are specially labeled because they are known as variable
regions. As I said previously, around the chromosome will be Par regions that contain the DNA of
these variable regions. What previous studies have shown is that homologous recombination
occurs to cause a different protein sequence to be expressed. The full or partial recombination
between the par regions and the expressed site leads to tremendously different possibilities
every time the cell undergoes meiosis. What this means is that the operon is initially expressing
the original B region. During replication, the organism may use homologous recombination to
swap out that B region with a new B region found in one of the Par regions. There are 9 par
regions containing different regions of the adhesin proteins. These can be recombined fully or
partially which is why so much variation is possible within a population of MG.
This is where my research on antibody binding came in. Knowing that M. genitalium can vary
its expressed protein within the variable regions, our general question to answer was how those
variants alter binding with the antibodies designed to bind to them. The antibodies that I used
were taken from infected primates and given to me by Dr. Gwen Wood after purification by Laarni
Aguila. Laarni also purified protein fragments of the adhesin protein MgpB. The regions that I
tested were 4a, a conserved region, and region B, a variable region. I also received a variant of
the B fragment. I will refer to this variant as the week 8 variant because it appeared in the
bacterial population 8 weeks after the initial infection. This means that after 8 weeks of an
infection, the bacteria that the immune system was fighting were slightly different than those
that initially began the infection. The variation that occurred in the week 8 variant totaled only a
few different bases, but this was enough to generate different amino acids. One you change the
secondary structure of a protein, that is to say, once you change the building blocks that it’s made
of, you change its shape. Different shapes, even microscopic changes in the overall shape, lead
to different molecular interactions between antibody and antigen and lead to different binding.
Chemists will often say that when you change the shape you change the function. In this case,
the evidence suggests that changing the shape changes the binding. To understand how these
fragments influence antibody-antigen interactions, I used a method called SPR to analyze the
binding events between the antibodies and their respective antigens. Once I understood how the
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antibodies were binding, I was able to compare the different regions and understand what was
happening to allow infections to persist.
Surface plasmon resonance is a method to collect real-time information on the interactions
between biomolecules. It is an important technique to understand interactions between
compounds because it gives insight into the kinetics of an interaction rather than just the affinity.
The general idea is that the machine shines a polarized laser into a surface. We use a gold surface
because it can conduct well. This will create plasmons which are electron charge density waves.
The reflected light’s intensity is reduced due to the plasmons, and it is reflected back at a specific
angle called the resonance angle. This angle is proportional to the mass present on the sensor
surface. This allows us to tell the difference between a chip’s surface that only contains antigen
and a chip’s surface that is holding antigen bound to antibody because the angle of reflection will
change. I used a method called amine-coupling that allows me to bind a protein to the surface
and block the rest of the chip’s surface from binding by flowing it over the chip’s surface. The
protein fragments that we used were MgpB:4a, a fragment of a conserved region in the MgpB
adhesin protein, MgpB:B, a variable region in the MgpB adhesin protein, and MgpB:B Week8,
which was the week eight variant of the MgpB:B fragment. Once I had confirmed that my ligand
has bound to the chip, I was able to flow different concentrations of antibodies over the chip.
The antibodies that I received were taken two weeks prior to infection, two weeks post
infection, four weeks post infection, and eight weeks post infection. I made serial dilutions of
antibodies so that I could gauge how concentration affected binding and so that the antibodies
from different weeks would have the same relative concentration when I tested them. I then ran
four trials of each week’s concentration gradient over all three chips. The chip is docked in the
BIAcore machine with the protein fragment attached. I then pipette a small volume of dilute
antibody into the machine where it will flow over the chip. The light that is being reflected off
the chip will sense when antibodies from my sample initially bind as well as when they dissociate
from the chip. The resulting curve allows me to calculate the kon and koff rates. The kon rates
describe how easy it is to form the initial interaction. The koff rates describe how easy it is to break
the interaction. Something with a high on and off rate wouldn’t necessarily be great for an
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important binding interaction because it would dissociate as soon as the two compounds came
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chip. Response units increase as antibodies bind, causing the mass on the chip to increase and
the angle of reflection to change. After the sample is done running over the chip, there is a
flushing of HBSEP solution, which is a salt solution that we use to clean the machine. This is the
same solution that I used to make dilute antibody samples and used to blank the instrument
initially, so any binding between the HBSEP salts and the chip will not be reflected in the graph.
The declining line seen in the graph is expressing the antibodies falling off the antigen. From this,
I can calculate both the association and dissociation rates.
ka

SE(ka)

kd

SE(kd)

Chip (Antibody)

KD

16043.67

5659.333

0.00395

0.000462

4a(wk-2)

2.46E-07

22280

8891.708

0.008226

0.001093

4a(wk2)

3.69E-07

122339.8

21855.45

0.004822

0.000725

4a(wk4)

3.94E-08

64566.67

13231

0.003532

0.000449

4a(wk8)

5.47E-08

11410

5232.278

0.003823

0.000677

B(Pwk-2)

3.35E-07

90993.89

35357.22

0.004794

0.001069

B(Pwk2)

5.27E-08

32868.33

17344.44

0.007477

0.001361

B(Pwk4)

2.76E-07

12444.17

5535.333

0.004191

0.000973

B(Pwk8)

3.37E-07

1492.783

996.4833

0.002618

0.000244

Bwk8(Pwk-2)

1.75E-06

18423.61

6254.167

0.003044

0.000579

Bwk8(Pwk2)

1.86E-07

30191.46

12774.17

0.011513

0.002859

Bwk8(Pwk4)

3.81E-07

12227.08

3847.917

0.004565

0.000513

Bwk8(Pwk8)

3.73E-07

72850

1511.25

0.002678

0.000156

B(G37)(rab)

3.68E-08

44350

2643.5

0.003063

0.000344

Bwk8(rab)

6.91E-08
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My overall data is described by this table. The colors demonstrate the binding affinities with
green showing tight binding and red showing weak binding. Starting with the chip holding the 4a
fragment, we see that binding is strongest with the week 4 antibody. This is also the strongest
overall binding during an association event out of any antibody week over any protein fragment.
The week 2 sample against the B fragment has the greatest association and affinity for either B
fragment. This is expected due to affinity maturation which is the process by which B cells will
create antibodies with increased affinity for their antigen over time. As the host is exposed to
more pathogen, the host will make antibodies with better binding. However, we then see a
decline in binding rather than a continual increase. With both B fragments, their association
kinetics are remarkably lower than the 4a fragment. Considering that the 4a fragment is of a
conserved region and the B fragment is of a variable region, it would make sense that the body
would choose to make antibodies for a conserved region rather than a variable region. The B
region changes over time based on the variants that it can use during homologous
recombination. Therefore, the immune system is in a reactive stage with the B region rather than
a proactive stage like with the 4a region. In this study, we are using chips bound with specific
regions of M. genitalium for antibody targeting. The antibodies that we collected were from
primates who were infected with the entire organism, not just a segment of the adhesin protein.
This means that the purified antibodies we used to conduct our studies would have contained
antibodies specific to region 4a, region B, region EF, region G, region KLM, and all of the regions
not associated with the adhesin protein. Those antibodies would not necessarily be present in
the same concentrations. In this case, the week 4 antibody sample that I ran over the region B
chip may have contained more 4a antibody than B antibody. This could explain why we see lower
levels of binding. Antibodies are made based on how well their B cell can be activated. So, all of
this is to say that we suspect that our antibody samples contained more antibodies specific to
region 4a than region B. Looking at our data in the broader sense, that means our body is not
treating each protein fragment the same---it is learning which antibodies to make based on what
is effective.
An interesting finding within the data for the B week 8 variant fragment is the extremely low
association kinetics for the week -2 antibodies. Looking at the three graphs of the different chips

20

next to each other, we would expect that initial binding affinity and k on rates to be similar over
all of the chips for the week -2 antibodies. Afterall, the week-2 antibody samples were sera taken
two weeks before the initial MG infection. Those primates had never been infected by MG, so
there would be no reason for them to have any MG antibodies. Therefore, we would expect
antibodies taken from this time-period to bind to the 4a, B, and B week 8 variants with about the
same rate. However, instead we see much lower binding in the variant. This suggests that the
variant that the bacterium uses affects general antibody binding, not just specific antibody
binding. Our antibodies look generally about the same. They are a bendy Y shape that contain
variable and constant regions. The variable regions are what allow such specific binding to a
specific pathogen when presented with a plethora of things to attack. However, it does not seem
as though the MG variant is affecting just the specific binding. Rather, it seems that the variant
causes antibodies in general to not bind as well. Later on, we still see weak binding with
antibodies from weeks 2, 4, and 8 within the B week 8 variant. This shows that after affinity
maturation, there is still lower binding. Despite having had enough time for the antibodies to
show stronger binding, they are still unable to bind as well as either the normal B fragment or
the 4a fragment. So, while the week 8 variant lessens general antibody binding, it is also lessening
specific antibody binding.
Something to note is that once we had collected all of our data with 4 trials of each antibody
over the three chips, the association kinetics varied 80-fold. The dissociation kinetics varied 4fold. So, while the table that I showed contained results of the dissociation kinetics, because they
varied inconsequentially compared to the association kinetics, we felt that the association
kinetics were a better representation of the antibody-antigen interactions occurring due to
variance. We also calculated the total KD. KD is the equilibrium dissociation constant, so a ratio
between koff and kon. It is inversely related to the affinity, and it relates to the concentration of
antibody necessary for a certain level of binding. When describing this, we can use the terms
micromolar, high-nanomolar, and mid-nanomolar. Since KD is inversely related to affinity, the
higher the KD, the lower the affinity between the antibody and antigen. Most of the 4a fragment
results were in the region of mid-nanomolar, meaning on the higher end of affinity. The B
fragment interactions were typically in the high-nanomolar range. Only the B variant for the
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week-2 antibody presented in the micromolar region, showing just how low the affinity was for
that interaction. We can take these results and boil it down to strongest binding between
antibody and antigen in region 4a, the conserved region. Second strongest binding in region B, a
variable region. Weakest binding in the week 8 variant of the B region.
The historical timeline of this project began with similar studies on rabbits. The rabbits were
infected with, rather than the entire organism, just the protein fragments. This allowed for the
understanding of the kinetic binding of protein fragments to only their specific antibody as well
as which protein fragments resulted in the highest and lowest affinity binding. From that
knowledge, my project on primate antibodies came to be. The importance of my research in
terms of an intermediate project was to show that binding could be detected at levels well
enough to show existing differences. The original antibody concentrations that I received were
already quite low, and I would then dilute the antibodies to around 1:1000 th. Showing that data
could be collected with such low concentrations was imperative before moving on to humans.
Continuing with human trials would not yield desirable results if we were unable to visualize
binding with the primate antibodies. Likely, this research will continue on with human antibodies
as well as different protein fragments, both of the conserved nature and different variable
regions. This knowledge will aid in designing more specific therapeutics in the future that can
target the regions most important for bacterial survival. The antibiotic resistance of this
bacterium continues to raise concern, and knowing that the conservative regions are the highest
targets for antibodies gives new information on what therapeutics should target next.
Later on, in this panel we will hear about interactions between teachers and students and
political leaders with their constituents. In each case we are dealing with humans interacting with
one another, either in a small setting or on a large scale. While these interactions are at the
forefront of our mind when we think about all of our daily interactions, there are a million cells
within our body, both foreign and domestic, that are demanding our attention as well. M.
genitalium is just one example of an organism requiring our consideration. As soon as we
disregard its abilities or potential impact, it can change its protein expression causing a raging
infection that cannot be ignored. There is a necessity of awareness to the world around us. In
Christian theology, humans are called upon to be stewards of nature. We are not called upon to
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passively observe, but to participate and protect. This may seem as though I am advocating for
the protection of M. genitalium, but I emphasize my point again that humans are part of nature.
That means we have a duty to participate with other organisms while protecting ourselves from
their threat. This calling of stewardship and responsibility demands that we recognize our own
place within nature and the impact we can have on it, but also the impact it can have on us.
When we talk about the evolution of organisms, we are talking about small changes in a
species over a large portion of time. We tend to think of ourselves as separate from the change
around us. However, our own body is modifying which antibodies it makes to be more effective
at protecting itself from its invaders. While the M. genitalium microbe was using its genetic
abilities to create variant versions of itself to evade the immune system, our immune system was
learning which regions weren’t variable and was targeting those constant regions. Part of what
it means to be human is to recognize that humans are animals that do not exist outside of the
rest of the world. We are our bodies, and we are constantly being forced to interact with other
organisms. It is our body’s responsibility to respond to the world around it, and we have the
obligation to not separate our physical body from our humanity. It is how the rest of the world
interacts with us and how we interact with the rest of the world.
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